In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance

https://doi.org/10.1016/0034-5288(93)90130-8Get rights and content

Abstract

The activities of danofloxacin, a novel fluoroquinolone, and two other antimicrobials were determined in vitro against field isolates of seven Mycoplasma species of veterinary importance isolated from cattle, swine and poultry in five European countries. The minimum inhibitory concentrations (MIC) of danofloxacin, tylosin and oxytetracycline were determined against a total of 68 isolates. Danofloxacin showed excellent activity against isolates of all Mycoplasma species (range 0·008 to 0·5 μg ml−1), but in some isolates there was evidence of reduced sensitivity to tylosin (range 0·008 to 2·0 μg ml−1) and oxytetracycline (range 0·008 to over 16·0 μg ml−1). Danofloxacin was more active than other antimicrobials against, M hyopneumoniae, M dispar and M bovigenitalium, and showed activity similar to that of tylosin against M bovis and M gallisepticum. Tylosin was the most active against M synoviae and M hyosynoviae. Generally, oxytetracycline showed the poorest activity, but was superior to tylosin against M bovigenitalium. A second (final) MIC reading was taken for all isolates 14 or 21 days after the initial reading, and MIC values rose during that time. However, the increase seen in danofloxacin values (typically one to two dilutions) was less than that seen for tylosin and oxytetracycline. It is concluded that danofloxacin is highly active in vitro against all of the Mycoplasma species tested, and thus shows great potential for the treatment of respiratory and other infections caused by Mycoplasma species in cattle, pigs and poultry.

References (17)

  • P.C.T. Hannan et al.

    In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens

    Research in Veterinary Science

    (1989)
  • L.B. Senterfit

    Antibiotic sensitivity testing of mycoplasmas

  • R.M. Chanock et al.

    Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO

  • N.F. Friis

    Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare

    Nordisk Veterinaermedicin

    (1975)
  • S.A. Froshauer et al.

    Antibacterial activity of danofloxacin (CP-76, 136) a new fluoroquinolone for use in veterinary medicine

  • C.J. Giles et al.

    Clinical pharmacokinetics of parenterally administered danofloxacin in cattle

    Journal of Veterinary Pharmacology and Therapeutics

    (1991)
  • P.C.T. Hannan et al.

    Treatment of experimental enzootic pneumonia of the pig by norfloxacin or its 6-chloro analogue

    Research in Veterinary Science

    (1990)
  • K.-H. Hinz et al.

    Studies in vivo on the efficacy of enrofloxacin against Mycoplasma gallisepticum

    Avian Pathology

    (1990)
There are more references available in the full text version of this article.

Cited by (66)

  • Single intravenous and oral pharmacokinetics of danofloxacin in the goat

    2021, Small Ruminant Research
    Citation Excerpt :

    Despite widespread concern regarding development of resistance to fluoroquinolones, this class of drugs is extensively used for antibacterial prevention and treatment, largely due to their broad spectrum of activity (Hannan et al., 1997; Walker, 2000; Martinez et al., 2006). Indeed, danofloxacin’s antimicrobial activity includes most gram-negative and some gram-positive bacteria, and Mycoplasma spp. (Grimshaw et al., 1990; McGuirk et al., 1992; Cooper et al., 1993). Goats are primarily farmed for meat and milk production, and worldwide their numbers are estimated at over one billion head and rising (Toutain et al., 2010; FAO, 2020).

  • Antimicrobial minimum inhibitory concentration of Mycoplasma gallisepticum: a systematic review

    2021, Journal of Applied Poultry Research
    Citation Excerpt :

    The main exclusion reason among studies selected for full-text assessment was the lack of consistency between broth microdilution MIC protocols that were used in the studies and the standard protocol. These include differences in viable counting methods (Jordan and Horrocks, 1996; Jordan et al., 1998; Zanella et al., 1998; Wang et al., 2001; Reinhardt et al., 2005; Forrester et al., 2011; Chen et al., 2015; Din et al., 2017), inoculum size (Cooper et al., 1993; Jordan and Horrocks, 1996; Jordan et al., 1998; Ammar et al., 2016), and the absence of an initial MIC value (Zanella et al., 1998; Pakpinyo and Sasipreeyajan, 2007; Din et al., 2017). For certain antibiotics and reference strains, different MIC was observed.

  • Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese

    2021, Research in Veterinary Science
    Citation Excerpt :

    The dose was chosen based on the recommended therapeutic regimen for the treatment of respiratory diseases in poultry (Charleston et al., 1998; Zhang et al., 2017). At this dose, danofloxacin showed activity against Mycoplasma species, such as M. gallisepticum, a common pathogen which can cause a chronic respiratory disease in poultry, affecting growth rate and egg production (Cooper et al., 1993; Zhang et al., 2017). In the current study, danofloxacin in geese showed a higher Cmax and a lower Tmax than those reported in chickens and ducks (Knoll et al., 1999; Goudah and Mouneir, 2009; Zeng et al., 2010).

  • In vitro pharmacodynamics of gamithromycin against Mycoplasma mycoides subspecies mycoides Small Colony

    2013, Veterinary Journal
    Citation Excerpt :

    Despite this, epidemiological models have predicted that vaccination campaigns alone are unlikely to result in disease eradication and treatment with antimicrobials should be evaluated (Mariner et al., 2006). Macrolides are one of three major antimicrobial classes that are effective against mycoplasmas, the others being tetracyclines and fluoroquinolones (Cooper et al., 1993). Gamithromycin is a new macrolide that was developed for the treatment and prevention of bovine respiratory disease and has been shown to possess both bacteriostatic and bactericidal activity against Mannheimia haemolytica (Huang et al., 2010).

  • Randomized masked controlled clinical trial to compare 7-day and 14-day course length of doxycycline in the treatment of Mycoplasma felis infection in shelter cats

    2013, Comparative Immunology, Microbiology and Infectious Diseases
    Citation Excerpt :

    Whether acting as a primary pathogen or secondary opportunistic invader, Mycoplasma spp. is an important infectious agent in feline URTD. Mycoplasma are susceptible to fluoroquinolones and tetracyclines in vitro and in vivo [14,17,18]. The tetracyclines (tetracycline, oxytetracycline, minocycline, and doxycycline) are bacteriostatic antibiotics that interfere with bacterial protein synthesis.

View all citing articles on Scopus
View full text